Lido Advisors
GILD icon

Lido Advisors’s Gilead Sciences GILD Stock Holding History

Lido Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,300
Closed -$405K – 2019
2025
Q4 		$405K Hold
3,300
– – ﹤0.01% 1394
2025
Q3 		$366K Hold
3,300
– – ﹤0.01% 1391
2025
Q2 		$366K Buy
+3,300
New +$351K ﹤0.01% 1247

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lido Advisors's GILD Position: Q2 2026 in Review

Lido Advisors increased its Gilead Sciences (GILD) stake by 28% in Q2 2026, buying an estimated $4.38M and bringing the position to 153,825 shares worth $19.4M. The position accounts for 0.05% of the portfolio, ranked #234.

Lido Advisors first reported a position in GILD in Q1 2016 and has held it in 39 quarters since. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Lido Advisors held 153,825 shares of Gilead Sciences worth $19.4M as of Q2 2026.
  • Lido Advisors bought 33,233 Gilead Sciences shares in Q2 2026, an estimated $4.38M.
  • Gilead Sciences made up 0.05% of Lido Advisors's portfolio in Q2 2026, its #234 holding.
  • Lido Advisors first reported a position in Gilead Sciences in Q1 2016 and has held it in 39 quarters since.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.